Diffuse tracer uptake in scintimammography: Not as nonspecific or benign as originally believed? [3]

Journal of Nuclear Medicine

Volumn 47, Issue 3, 2006, Pages 554-555

  Papantoniou, Vassilios ^a   Ptohis, Nikolaos ^a   Tsiouris, Spyridon ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; SUCCIMER TC 99M; TRACER; DIAGNOSTIC AGENT;

BREAST CANCER; BREAST LESION; CANCER DIAGNOSIS; CANCER RECURRENCE; CELL PROLIFERATION; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG UPTAKE; FALSE POSITIVE RESULT; HUMAN; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LETTER; MAMMOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADULT; AGED; BREAST TUMOR; FEMALE; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; NOTE; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33645961028     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Mathieu I, Mazy S, Willemart B, Destine M, Mazy G, Lonneux M. Inconclusive triple diagnosis in breast cancer imaging: is there a place for scintimammography? J Nucl Med. 2005;46:1574-1581.
2. Papantoniou V, Tsiouris S, Mainta E, et al. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Breast Cancer Res. 2005;7:R33-R45.
3. Breast Imaging Reporting and Data System (BI-RADS). 2nd ed. Reston, VA: American College of Radiology; 1995.
4. 99mTc-(V)DMSA uptake in breast cancer. Breast Cancer Res. 2004;6:R56-R62.
5. 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging. 2005;32:820-827.
6. Cutrone JA, Yospur LS, Khalkhali I, Tolmos J, Devito A, Diggles L. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med. 1998;39:449-453.
7. Cwikla JB, Buscombe JR, Kolasinska AD, Parbhoo SP, Thakrar DS, Hilson AJ. Correlation between uptake of Tc-99m sesta-MIBI and prognostic factors of breast cancer. Anticancer Res. 1999;19:2299-2304.